SCHEMBL7001532

SCHEMBL7001532

O=C(NCCN1CCNCC1)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.54
CHEK1 O14757 13/20 0.53
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CDK1 P06493 1/20 0.47
CDK2 P24941 1/20 0.47
SGK1 O00141 1/20 0.46
CHEK2 O96017 1/20 0.46
PRKCG P05129 1/20 0.46
AKT1 P31749 1/20 0.46
AKT2 P31751 1/20 0.46
MARK2 Q7KZI7 1/20 0.46
AKT3 Q9Y243 1/20 0.46
KCNH2 Q12809 1/20 0.45
HPGD P15428 1/20 0.44
CD274 Q9NZQ7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7092358 0.96 CHEK1 (0.52) KDRCHEK1KDM4EGAAHSD17B10
SCHEMBL7090478 0.95 KDR (0.52) KDRCHEK1CDK1CDK2SGK1
SCHEMBL7696826 0.93 CHEK1 (0.58) KDRCHEK1CDK1CDK2SGK1
SCHEMBL7094335 0.93 KDR (0.64) KDRCHEK1CDK1CDK2KCNH2
SCHEMBL7700734 0.92 CHEK1 (0.57) KDRCHEK1CDK1CDK2SGK1
SCHEMBL7703530 0.92 CHEK1 (0.57) KDRCHEK1CDK1CDK2SGK1
SCHEMBL7096443 0.91 KDR (0.49) KDRCHEK1CDK1CDK2SGK1
SCHEMBL7094673 0.90 CD274 (0.59) KDRCHEK1HPGDCD274
Water SCHEMBL7695501 0.89 CD274 (0.58) KDRCHEK1HPGDCD274
SCHEMBL7093818 0.87 KDR (0.54) KDRCHEK1CDK1CDK2SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed